News

Steroid-refractory acute GvHD is a serious and life-threatening ... weeks" and has a couple of years' worth of inventory on hand. He was a little coy on pricing, saying that it would be in line ...
Graft Versus Host Disease (GVHD) is a severe medical condition that can occur after a stem cell or bone marrow transplant. In GVHD, the donor's immune cells attack the recipient's healthy tissues ...
The FDA has approved Incyte's axatilimab as a treatment for chronic graft-versus-host disease (GvHD), making it a companion to the company's Jakafi for the disorder. The US regulator has cleared ...
Considering taking supplements to treat graft versus host disease gvhd? Below is a list of common natural remedies used to treat or reduce the symptoms of graft versus host disease gvhd.
Allogeneic hematopoietic stem cell transplantation (HSCT) is an important and potentially curative treatment of haematological malignancies, but GvHD and infections affect outcomes. We present ...
Itolizumab showed significant long-term benefits in acute GVHD, improving complete response duration and failure-free survival. Equillium, Inc. seeks Breakthrough Therapy designation and Accelerated ...
In addition to her GVHD research, Dr. Flowers studies the effectiveness of using donated lymphocytes, a type of immune cell, to treat recurrent malignancies after transplantation with donated cells.
OncoImmune’s lead product is CD24Fc, a first-in-class recombinant fusion protein in development for the prophylactic treatment of graft-versus-host disease (GVHD) that preserves or enhances the ...